Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Medulloblastoma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Diabetes Mellitus 2 Vomiting 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Premature Birth 1 Pre-Eclampsia 1 Polycystic Ovary Syndrome 1 Parathyroid Neoplasms 1 Neoplasms 1 Medulloblastoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Leiomyosarcoma 1 Hyperparathyroidism, Primary 1 Hot Flashes 1 Erectile Dysfunction 1 Cognitive Dysfunction 1 Carcinoma, Renal Cell 1

Interventions

Vincristine 4 Platinum 4 Cyclophosphamide 4 Cisplatin 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Radiation 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Specimen Handling 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Lomustine 2 Carboplatin 2 sodium thiosulfate 1 merphos 1 Thiotepa 1 Tablets 1 Stem Cell Transplantation 1 Spinal Puncture 1 Methotrexate 1 Leucovorin 1 Isotretinoin 1 Hearing 1 Fentanyl 1 Evoked Potentials, Auditory, Brain Stem 1 Etoposide 1 Donepezil 1 Cyproheptadine 1 Craniospinal Irradiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡